Impact of increased access to novel agents on the survival of multiple myeloma patients treated at a single New Zealand centre
ConclusionIn the setting of a NZ hospital the increased availability of NA was associated with a significant improvement in both the OS of older patients and the PFS of ASCT patients.This article is protected by copyright. All rights reserved.
Source: Internal Medicine Journal - Category: Internal Medicine Authors: Barry D. Hock,
Katie S. Mulholland,
Peter Ganly,
Judith L. McKenzie,
John F. Pearson,
Sean A. MacPherson Tags: Original Article Source Type: research
More News: Internal Medicine | Myeloma | New Zealand Health | Stem Cell Therapy | Stem Cells | Study | Transplants | Velcade